Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David S Miller
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
650 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mcgill University Health Centre at Royal Victoria Hospital
Montreal, Quebec, Canada
- Montreal General Hospital
Montreal, Quebec, Canada
- Saint Mary'S Hospital
Montreal, Quebec, Canada
- Chu de Quebec-L'Hotel-Dieu de Quebec (hdq)
Québec, Quebec, Canada
- Tohoku University School of Medicine
Sendai, Aoba-ku, Japan
- Kure National Hospital
Kure, Hiroshima, Japan
- Hokkaido University Hospital
Sapporo, Hokkaido, Japan
- Iwate Medical University Hospital
Shiwa-gun, Iwate, Japan
- Kagoshima City Hospital
Kagoshima, Kagoshima-ken, Japan
- Jikei University Aoto Hospital
Katsushika-ku, Tokyo, Japan
- Keio University
Shinjuku-ku, Tokyo, Japan
- Hiroshima University Hospital
Hiroshima, Japan
- National Hospital Organization-Kobe Medical Center
Kobe, Japan
- Shikoku Cancer Center
Matsuyama, Japan
- National Kyushu Cancer Center
Minamiku, Japan
- Jikei University School of Medicine
Minato-ku, Tokyo, Japan
- Saitama Medical University International Medical Center
Saitama, Japan
- National Cancer Center Hospital
Tokyo, Japan
- Tottori University
Tottori, Japan
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Clearview Cancer Institute
Huntsville, Alabama, United States
- Mobile Infirmary Medical Center
Mobile, Alabama, United States
- Providence Hospital
Mobile, Alabama, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Highlands Oncology Group Pa - Fayetteville
Fayetteville, Arkansas, United States
- Washington Regional Medical Center - Fayetteville
Fayetteville, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- John Muir Medical Center-Concord Campus
Concord, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Saint Jude Medical Center
Fullerton, California, United States
- Marin Cancer Care Inc
Greenbrae, California, United States
- Long Beach Memorial Medical Center-Todd Cancer Institute
Long Beach, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Community Hospital of Los Gatos
Los Gatos, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 25 Aug 2003
- Primary completion
- 29 Jun 2013
- Completion
- 5 Jan 2021
- Last update posted
- 19 Oct 2021
- Registered enrollment
- 1,381
- Registry id
- NCT00063999
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.